Latest Feature Articles

nerves

Parkinson’s disease: A quest for steadier therapies

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …

Insider Interview: Gilead’s fight against HIV comes into bloom

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Gilead, HIV, Insider Interview, pharma

Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …

john_crowley_edit

John Crowley speaks on drug development and the FDA

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.

ethan__drew_web

Living with an undiagnosed condition

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | feature, patient experience, pharma

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …

Bringing the PRO to fruition

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …

cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …

eye

All eyes on dry eye disease

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | TopiVert, dry eye disease, eye, pharma

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …

sugar_tax

The UK sugar tax: A sweet or sour move?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …

medopad

Connecting patients to doctors

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

becca

Health to hand

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

tony_green_edit

Living with atrial fibrillation

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | KardiaMobile, Tony Green, atrial fibrillation, patient experience

Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …

shutterstock_244903099

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …

The Gateway to Local Adoption Series

Latest content